Global Life-Long Health Benefits of Repression of Hypothalamic NPY System by Central Leptin Gene Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|7|17|1675-1681

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.17, 2007-09, pp. : 1675-1681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Keeping Obesity and Metabolic Syndrome at Bay with Central Leptin and Cytokine Gene Therapy

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 3, 2003-09 ,pp. : 189-199

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy Targeting in the Central Nervous System

By  

Current Gene Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 127-145

Bentham Science Publishers

Access to resources Recommend Favorite

Liposomal and Viral Vectors for Gene Therapy of the Central Nervous System

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 453-465

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy-Mediated Modulation of Immune Processes in the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 9, Iss. 24, 2003-09 ,pp. : 2002-2008

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of leptin administration versus re-feeding on hypothalamic neuropeptide gene expression in fasted male rats

By McAlister Edward D   Van Vugt Dean A  

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 12, 2004-12 ,pp. : 1128-1134

NRC Research Press

Access to resources Recommend Favorite